… Lung cancer (LC) is the dominant cause of death by cancer in the world, being responsible
for more than a million deaths annually. It is a highly lethal common tumor that is frequently …

… ‘lung cancer likelihood in plasma’ (Lung-CLiP), which can robustly discriminate early-stage
lung cancer … Our findings establish the potential of cfDNA for lung cancer screening and …

… performed integrative genomic analysis based on a set of lung cancer patients and had no
prospective clinical protocol or analysis plan. The associations between genomic features (…

… promising benefit in lung cancer, but predictors of response to combination therapy are
unknown. Using whole-exome sequencing to examine non-small-cell lung cancer (NSCLC) …

… cancers were analyzed separately given the well-established differences in mutational
landscape between these tumor types. The genomic … and squamous cell lung cancers. For …

… Genomic updates about MPLC Genomic characteristics of multifocal lung cancer started
over 25 years ago (64). With the development of science and technology and the progress of …

… We then assessed correlations among genomic and immune features and identified four
clusters of inter-correlated features centered on RTK mutations, HLA genetic variation, tumor …

… the diagnostic evaluation of patients with suspect lung cancer. Determining which suspect
lung cancer patients with lung cancer-negative bronchoscopies should undergo these …

… The germline mutation landscape in Chinese lung cancer patients has not been well
defined. In this study, sequencing data of 1,021 cancer genes of 1,794 Chinese lung cancer …

… In this study, we investigated the genomic features of Chinese SCLC patients. … cancer that
kills ~ 250,000 people worldwide annually and accounts for approximately 15% of lung cancer …